Health & Fitness

According to FutureWise analysis, the market for breast cancer screening in 2023 is US$2.06 billion, and is expected to reach US$3.87 billion by 2031 at a CAGR of 8.20%. The global breast cancer screening market is experiencing significant growth, with current valuations estimated between USD 2.9 billion and USD 4.4 billion. This range reflects the differentiation between the overall screening market and the specific segment focused on screening tests. Over the next decade, projections suggest that the market will nearly double, potentially reaching between USD 6.7 billion and USD 8.8 billion by the early to mid-2030s. Several factors contribute to this robust growth trajectory, including a compound annual growth rate (CAGR) estimated to be between 7% and 8.7%. One of the primary drivers is the increasing prevalence of breast cancer, which has heightened the demand for early detection and screening services. Furthermore, advancements in technology are playing a crucial role in ... Continue reading →

According to FutureWise analysis, the market for breast imaging in 2023 is US$5.12 billion, and is expected to reach US$10.22 billion by 2031 at a CAGR of 9%. FutureWise Market Research has unveiled an in-depth report that dives deep into the dynamic trends shaping the Breast Imaging Market. This comprehensive analysis reveals critical insights into profitability, a detailed SWOT analysis, market share distribution, and the geographical expansion of this sector. Additionally, the report sheds light on the current standing of leading players within the competitive landscape, providing a holistic view of the market. According to the diligent research conducted by FutureWise analysts, the Breast Imaging Market is poised for remarkable growth as we approach the end of the forecast period. The findings indicate that this sector is set to experience a significant growth rate during this timeframe. The report not only highlights the total market valuation currently held but also breaks down ... Continue reading →

According to FutureWise analysis, the market for breast implants in 2023 is US$2.49 billion, and is expected to reach US$4.55 billion by 2031 at a CAGR of 7.80%. Breast implants are artificial medical devices designed to enhance the natural size of breasts. They may be used for aesthetic purposes, reconstructive surgery following mastectomy, or to correct abnormalities. The cost of breast implant and augmentation surgery is significant, making the patient's socio-economic status an important factor. According to the American Society of Plastic Surgeons (ASPS), the average cost of breast augmentation surgery is estimated to be around $3,708. Since women are the primary customers of the global breast implant market, their income, purchasing power, and economic status play a crucial role in demand. An increase in their earnings is expected to boost disposable income and further drive market growth in the forecast period. Furthermore, improvements in reimbursement rates for ... Continue reading →

According to FutureWise analysis, the market for breast pumps in 2023 is US$2.94 billion, and is expected to reach US$5.78 billion by 2031 at a CAGR of 8.8%. The global breast pump market is experiencing significant and robust growth, currently valued at approximately USD 2.9 billion in 2023. Analysts forecast that this market could expand substantially, with projections estimating a value between USD 5.2 billion by 2030 and reaching as high as USD 8.1 billion by 2035. This translates to a compound annual growth rate (CAGR) ranging from 8.4% to 9.3%. Several key factors are driving this upward trend. One of the primary influences is the increasing participation of women in the workforce, particularly in emerging markets where traditional norms are changing. As more mothers balance professional responsibilities with breastfeeding, the demand for efficient and convenient breast pumps rises. In addition to changing workforce dynamics, technological advancements are making a significant ... Continue reading →

Having an effective medium of medical transport at the service of the patients would be highly beneficial as it can allow the evacuation mission to be completed without intending to cause trouble midway. With the round-the-clock, medically fitted Train Ambulance in Patna offered by Panchmukhi, the medical transfer turns out to be extremely effective. We never cause difficulties at the time of relocating critical patients and ensure the entire trip is composed based on the urgency of the situation. Our medical transfer is arranged inside trains where booked compartments are equipped with state-of-the-art equipment that offers the proper hospital-like environment that is required at the time of an emergency. Safer medical transportation can be expected at our company, where patients are taken care of all along the way and offered the right care and attention until the journey is over. At our Best Patient Shifting Train Ambulance Service in Patna, you won’t experience any ... Continue reading →

According to FutureWise analysis the market for aortic valve in 2023 was US$ 12.41 billion, and is expected to reach US$ 33.99 billion by 2031 at a CAGR of 13.42%. The aortic valve plays a crucial role in the functioning of the human heart, serving as a key regulator of blood flow within the cardiovascular system. Located between the left ventricle and the aorta, this semilunar valve is essential for the effective distribution of oxygenated blood throughout the body. As the left ventricle contracts, the aortic valve opens, enabling blood to flow into the aorta.During the contraction of the left ventricle, the aortic valve opens, allowing blood to flow into the aorta. When the ventricle relaxes, the valve closes to prevent the backflow of blood into the heart. Maintaining the health of the aortic valve is vital for optimal cardiac performance; however, various conditions can lead to its dysfunction. One common issue is aortic stenosis, which occurs when the aortic valve becomes ... Continue reading →

According to FutureWise analysis the market for aphakia is expected to reach US$ 4.32 billion by 2031 at a CAGR of 11.40%. Aphakia refers to a medical condition where the lens of the eye is missing. The lens, located behind the iris and pupil, is essential for focusing light onto the retina, which is necessary for clear vision. When the lens is absent, the eye's ability to focus diminishes, often resulting in blurred vision. The most common cause of aphakia is cataract surgery, during which a natural lens becomes clouded, is removed, and is frequently replaced with an intraocular lens (IOL). In certain situations, particularly in infants or confident older children, an IOL may not be implanted, leaving the individuals aphakic. Traumatic injuries to the eye can also result in damage to the lens or even complete lens loss. Rare congenital conditions can also result in individuals being born without lenses or with lenses that are malformed. Symptoms of aphakia typically include ... Continue reading →

According to FutureWise analysis, the market for Apheresis is expected to grow with a CAGR of 8.3% over the forecast period 2025-2033, and reach a market value of US$ 4.36 billion by 2031. Apheresis is a medical procedure designed to selectively remove specific components from an individual's blood while returning the remaining components back to the body. This technique is often referred to as "hemapheresis." The process utilizes a specialized device called an apheresis machine, which efficiently separates blood into its different components—like plasma, red blood cells, white blood cells, and platelets—through a combination of centrifugation and filtration techniques. There are several distinct types of apheresis procedures, each catering to different medical needs: - **Plasmapheresis** focuses on the removal of plasma, the liquid portion of blood that contains proteins, antibodies, and clotting factors. This procedure is particularly beneficial for ... Continue reading →

According to FutureWise analysis the market for Apixaban in 2023 is US$ 1.87 billion, and is expected to reach US$ 2.96 billion by 2031 at a CAGR of 5.90%. Apixaban is a blood thinner that falls under the category of direct oral anticoagulants (DOACs). Apixaban is a blood thinner that falls under the category of direct oral anticoagulants (DOACs). It is commonly marketed under the brand name Eliquis, among others. This medication is primarily prescribed to prevent blood clots and reduce the risk of strokes in patients with specific medical conditions, particularly those diagnosed with atrial fibrillation, deep vein thrombosis (DVT), or pulmonary embolism (PE). These conditions involve the presence of blood clots in the veins. One of the advantages of apixaban over traditional anticoagulants, such as warfarin, is that it does not require regular monitoring of blood levels or frequent dose adjustments. Instead, apixaban is typically administered orally at a fixed dose, which enhances ... Continue reading →

According to FutureWise analysis the market for aplastic anemia treatment is expected to reach US$ 10.55 billion by 2031 at a CAGR of 5.32%. Aplastic anemia is a rare yet serious medical condition marked by a significant shortage of blood cells. This disorder occurs when the bone marrow, which is responsible for producing red blood cells, white blood cells, and platelets, fails to produce an adequate amount of these vital components. As a result, individuals with aplastic anemia commonly experience a decline in red blood cell counts, leading to anemia. Symptoms of anemia can include fatigue, weakness, and an increased susceptibility to infections. In addition to affecting red blood cells, aplastic anemia can also reduce the number of white blood cells, which compromises the body's ability to fight off infections. Furthermore, a decrease in platelets—essential for blood clotting—can result in easy bruising and bleeding. The condition can be triggered by various factors, ... Continue reading →